导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.03% | 795/1050 |
| 近一周 | -0.55% | 372/1104 |
| 近一月 | -1.16% | 254/1103 |
| 近一季 | -17.22% | 914/1092 |
| 近半年 | -11.39% | 814/1070 |
| 近一年 | -6.20% | 680/1018 |
| 近两年 | 30.89% | 674/926 |
| 近三年 | 4.89% | 630/834 |
| 成立以来 | 116.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.25% 570/1070 |
15.42% 442/1101 |
- - |
- - |
| 2025 | 17.98% 699/1065 |
0.14% 791/1014 |
1.56% 547/1038 |
16.01% 727/1050 |
-0.01% 453/1065 |
| 2024 | -4.49% 687/1011 |
-4.93% 562/960 |
-3.80% 562/983 |
4.96% 888/991 |
-0.49% 346/1011 |
| 2023 | -3.93% 178/952 |
6.76% 230/880 |
-3.60% 423/895 |
-7.62% 478/915 |
1.05% 93/952 |
| 2022 | -32.55% 671/867 |
-18.86% 461/773 |
7.03% 405/806 |
-12.58% 433/845 |
-11.15% 809/867 |
| 2021 | 15.69% 187/740 |
-0.61% 179/580 |
10.96% 330/659 |
-1.36% 241/704 |
6.35% 167/740 |
| 2020 | 86.04% 72/554 |
- - |
- - |
16.06% 129/517 |
22.08% 101/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华泰保兴多策略 VS. 东吴新产业精选股票A(580008) |